Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone)

a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available

Anne L Langston, Marie Johnston, Jill Francis, Clare Robertson, Marion K Campbell, Vikki A Entwistle, Theresa Marteau, Graeme Maclennan, John Weinman, Marilyn McCallum, Zosia Miedzybrodska, Keith Charnock, Stuart H Ralston, Zosia Miedzybrodzka

Research output: Contribution to journalArticle

3 Citations (Scopus)
4 Downloads (Pure)

Abstract

Background: Paget's disease of bone (PDB) disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors play a role in PDB and genetic tests are now conducted for research purposes. It is thus timely to investigate the potential for a clinical programme of genetic testing and preventative treatment for people who have a family history of PDB. This study examines the beliefs of relatives of people with PDB. It focuses particularly on illness and treatment representations as predictors of the acceptability and uptake of potential clinical programmes. Illness representations are examined using Leventhal's Common Sense Self-Regulation Model while cognitions about treatment behaviours (acceptance of testing and treatment uptake) are conceptualised within the Theory of Planned Behaviour.

Methods/Design: A postal questionnaire of non-affected relatives of people with Paget's disease. The sample will include relatives of Paget's patients with a family history of Paget's disease and relatives of Paget's patients without a family history of Paget's disease. The questionnaire will explore whether a range of factors relate to acceptability of a programme of genetic testing and preventive treatment in relatives of Paget's disease sufferers. The questionnaire will include several measures: illness representations (as measured by the Brief Illness Perceptions Questionnaire); treatment representations (as measured by Theory of Planned Behaviour-based question items, informed by a prior interview elicitation study); descriptive and demographic details; and questions exploring family environment and beliefs of other important people. Data will also be collected from family members who have been diagnosed with Paget's disease to describe the disease presentation and its distribution within a family.

Discussion: The answers to these measures will inform the feasibility of a programme of genetic testing and preventive treatment for individuals who are at a high risk of developing Paget's disease because they carry an appropriate genetic mutation. They will also contribute to theoretical and empirical approaches to predicting diagnostic and treatment behaviours from the combined theoretical models.

Original languageEnglish
Pages (from-to)116
Number of pages13
JournalBMC Health Services Research
Volume8
Issue number116
DOIs
Publication statusPublished - 29 May 2008

Keywords

  • illness perception questionnaire
  • planned behavior
  • familial aggregation
  • domain mutations
  • measles-virus
  • SQSTM1
  • consequences
  • risedronate
  • frequency
  • responses

Cite this

Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone) : a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available. / Langston, Anne L; Johnston, Marie; Francis, Jill; Robertson, Clare; Campbell, Marion K; Entwistle, Vikki A; Marteau, Theresa; Maclennan, Graeme; Weinman, John; McCallum, Marilyn; Miedzybrodska, Zosia; Charnock, Keith; Ralston, Stuart H; Miedzybrodzka, Zosia.

In: BMC Health Services Research, Vol. 8, No. 116, 29.05.2008, p. 116.

Research output: Contribution to journalArticle

@article{05cdd3374ac84c14baf8e1a9735b3dfc,
title = "Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available",
abstract = "Background: Paget's disease of bone (PDB) disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors play a role in PDB and genetic tests are now conducted for research purposes. It is thus timely to investigate the potential for a clinical programme of genetic testing and preventative treatment for people who have a family history of PDB. This study examines the beliefs of relatives of people with PDB. It focuses particularly on illness and treatment representations as predictors of the acceptability and uptake of potential clinical programmes. Illness representations are examined using Leventhal's Common Sense Self-Regulation Model while cognitions about treatment behaviours (acceptance of testing and treatment uptake) are conceptualised within the Theory of Planned Behaviour.Methods/Design: A postal questionnaire of non-affected relatives of people with Paget's disease. The sample will include relatives of Paget's patients with a family history of Paget's disease and relatives of Paget's patients without a family history of Paget's disease. The questionnaire will explore whether a range of factors relate to acceptability of a programme of genetic testing and preventive treatment in relatives of Paget's disease sufferers. The questionnaire will include several measures: illness representations (as measured by the Brief Illness Perceptions Questionnaire); treatment representations (as measured by Theory of Planned Behaviour-based question items, informed by a prior interview elicitation study); descriptive and demographic details; and questions exploring family environment and beliefs of other important people. Data will also be collected from family members who have been diagnosed with Paget's disease to describe the disease presentation and its distribution within a family.Discussion: The answers to these measures will inform the feasibility of a programme of genetic testing and preventive treatment for individuals who are at a high risk of developing Paget's disease because they carry an appropriate genetic mutation. They will also contribute to theoretical and empirical approaches to predicting diagnostic and treatment behaviours from the combined theoretical models.",
keywords = "illness perception questionnaire, planned behavior, familial aggregation, domain mutations, measles-virus, SQSTM1, consequences, risedronate, frequency, responses",
author = "Langston, {Anne L} and Marie Johnston and Jill Francis and Clare Robertson and Campbell, {Marion K} and Entwistle, {Vikki A} and Theresa Marteau and Graeme Maclennan and John Weinman and Marilyn McCallum and Zosia Miedzybrodska and Keith Charnock and Ralston, {Stuart H} and Zosia Miedzybrodzka",
year = "2008",
month = "5",
day = "29",
doi = "10.1186/1472-6963-8-116",
language = "English",
volume = "8",
pages = "116",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "116",

}

TY - JOUR

T1 - Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone)

T2 - a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available

AU - Langston, Anne L

AU - Johnston, Marie

AU - Francis, Jill

AU - Robertson, Clare

AU - Campbell, Marion K

AU - Entwistle, Vikki A

AU - Marteau, Theresa

AU - Maclennan, Graeme

AU - Weinman, John

AU - McCallum, Marilyn

AU - Miedzybrodska, Zosia

AU - Charnock, Keith

AU - Ralston, Stuart H

AU - Miedzybrodzka, Zosia

PY - 2008/5/29

Y1 - 2008/5/29

N2 - Background: Paget's disease of bone (PDB) disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors play a role in PDB and genetic tests are now conducted for research purposes. It is thus timely to investigate the potential for a clinical programme of genetic testing and preventative treatment for people who have a family history of PDB. This study examines the beliefs of relatives of people with PDB. It focuses particularly on illness and treatment representations as predictors of the acceptability and uptake of potential clinical programmes. Illness representations are examined using Leventhal's Common Sense Self-Regulation Model while cognitions about treatment behaviours (acceptance of testing and treatment uptake) are conceptualised within the Theory of Planned Behaviour.Methods/Design: A postal questionnaire of non-affected relatives of people with Paget's disease. The sample will include relatives of Paget's patients with a family history of Paget's disease and relatives of Paget's patients without a family history of Paget's disease. The questionnaire will explore whether a range of factors relate to acceptability of a programme of genetic testing and preventive treatment in relatives of Paget's disease sufferers. The questionnaire will include several measures: illness representations (as measured by the Brief Illness Perceptions Questionnaire); treatment representations (as measured by Theory of Planned Behaviour-based question items, informed by a prior interview elicitation study); descriptive and demographic details; and questions exploring family environment and beliefs of other important people. Data will also be collected from family members who have been diagnosed with Paget's disease to describe the disease presentation and its distribution within a family.Discussion: The answers to these measures will inform the feasibility of a programme of genetic testing and preventive treatment for individuals who are at a high risk of developing Paget's disease because they carry an appropriate genetic mutation. They will also contribute to theoretical and empirical approaches to predicting diagnostic and treatment behaviours from the combined theoretical models.

AB - Background: Paget's disease of bone (PDB) disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors play a role in PDB and genetic tests are now conducted for research purposes. It is thus timely to investigate the potential for a clinical programme of genetic testing and preventative treatment for people who have a family history of PDB. This study examines the beliefs of relatives of people with PDB. It focuses particularly on illness and treatment representations as predictors of the acceptability and uptake of potential clinical programmes. Illness representations are examined using Leventhal's Common Sense Self-Regulation Model while cognitions about treatment behaviours (acceptance of testing and treatment uptake) are conceptualised within the Theory of Planned Behaviour.Methods/Design: A postal questionnaire of non-affected relatives of people with Paget's disease. The sample will include relatives of Paget's patients with a family history of Paget's disease and relatives of Paget's patients without a family history of Paget's disease. The questionnaire will explore whether a range of factors relate to acceptability of a programme of genetic testing and preventive treatment in relatives of Paget's disease sufferers. The questionnaire will include several measures: illness representations (as measured by the Brief Illness Perceptions Questionnaire); treatment representations (as measured by Theory of Planned Behaviour-based question items, informed by a prior interview elicitation study); descriptive and demographic details; and questions exploring family environment and beliefs of other important people. Data will also be collected from family members who have been diagnosed with Paget's disease to describe the disease presentation and its distribution within a family.Discussion: The answers to these measures will inform the feasibility of a programme of genetic testing and preventive treatment for individuals who are at a high risk of developing Paget's disease because they carry an appropriate genetic mutation. They will also contribute to theoretical and empirical approaches to predicting diagnostic and treatment behaviours from the combined theoretical models.

KW - illness perception questionnaire

KW - planned behavior

KW - familial aggregation

KW - domain mutations

KW - measles-virus

KW - SQSTM1

KW - consequences

KW - risedronate

KW - frequency

KW - responses

U2 - 10.1186/1472-6963-8-116

DO - 10.1186/1472-6963-8-116

M3 - Article

VL - 8

SP - 116

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 116

ER -